BBIBP‐CorV – Sinopharm‐Beijing vs placeboConfirmed SARS‐CoV‐2 infection1 finding from 1 reviewEfficacy and safety of COVID‐19 vaccines 2022 · Cochrane Headline outcomes onlyno estimate extracted1 study · 25435 participantsHigh